South Africa:IFP - Medicines Control Council Must Urgently Approve Bacillus Calmette Guerin Vaccine
[IFP] The Inkatha Freedom Party calls on the Medicines Control Council to urgently approve the all-important Bacillus Calmette-Gu érin (BCG) vaccine, which protects the child from severe types of Tuberculosis (TB). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 31, 2018 Category: African Health Source Type: news
Fresh approach to TB vaccine offers better protection
(Oregon Health& Science University) A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans. The new vaccine completely protected 41 percent and reduced overall TB disease by 68 percent in vaccinated rhesus macaques, according to a study published as an Advanced Online Publication of Nature Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2018 Category: International Medicine & Public Health Source Type: news
Investigation Raises Concerns About Animal Study Misreporting
(MedPage Today) -- TB vaccine debacle traced to cherry-picked results from preclinical models (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 11, 2018 Category: American Health Source Type: news
TB vaccine that killed monkeys given to 1,400 babies
An information sheet given to the parents of the babies said the vaccine had been tested on animals and was ‘shown to be safe and effective’. But it did not mention the failed monkey trial. (Source: the Mail online | Health)
Source: the Mail online | Health - January 11, 2018 Category: Consumer Health News Source Type: news
Bacillus Calmette-Guerin Vaccination and Childhood Asthma Bacillus Calmette-Guerin Vaccination and Childhood Asthma
While some have speculated that BCG vaccination in infancy might protect against childhood asthma, the results of this study proved disappointing.American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 3, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
How tuberculosis hides in the body
(Norwegian University of Science and Technology) The tuberculosis vaccine only works for children. BCG (bacille Calmette-Guerin) doesn't protect you as an adult. Now we know more about how the bacterium avoids being detected, which is an important step towards better treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 28, 2017 Category: Infectious Diseases Source Type: news
Global Health: Lasting Merit Found in a Tuberculosis Vaccine Invented a Century Ago
BCG vaccine, used in many countries, protects for nearly twice as long as previously thought, scientists find. (Source: NYT Health)
Source: NYT Health - September 1, 2017 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Tuberculosis International Journal of Epidemiology Source Type: news
TB vaccine BCG effective for twice as long as previously thought – study
Benefits of world ’s only vaccine against tuberculosis were underestimated as new findings reveal it protects against the disease for at least 20 yearsThe BCG, an old vaccine but the only one against tuberculosis, is more effective than was thought, offering protection for at least 20 years, a new study shows.BCG vaccination used to be routine in all secondary schools in the UK for young teenagers, but in recent years it has been given only to those at risk, such as children living in inner-city areas with relatively high TB rates.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 31, 2017 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Tuberculosis Health Society Science UK news Source Type: news
BCG jab may protect against TB for nearly twice as long as previously thought
(London School of Hygiene& Tropical Medicine) The world's only licensed tuberculosis (TB) vaccine could offer protection against the disease for nearly twice as long as previously thought, according to new research published in the International Journal of Epidemiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2017 Category: International Medicine & Public Health Source Type: news
Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 22, 2017 Category: American Health Authors: W. Scott Bailey Source Type: news
Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 21, 2017 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news
TX Biomed part of team on 5-year, $4.4 million NIH grant for novel TB vaccine testing
(Texas Biomedical Research Institute) Texas Biomedical Research Institute Associate Scientist Dr. Marie-Claire Gauduin has partnered with Dr. Chinnaswamy Jagannath, professor at McGovern Medical School at UTHealth in Houston to test a modified TB vaccine that, if effective, could prove more powerful and provide longer lasting immunity. Dr. Gauduin and Dr. Jagannath are principal investigators on this five-year, $4.4 million study funded by the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 21, 2017 Category: International Medicine & Public Health Source Type: news
Tuberculosis Vaccine Candidate MTBVAC Shows Differential Protection Compared With BCG
According to Dr. Nacho Aguiló first author of the study, "there are no specific antigens associated with the efficacy of (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - July 18, 2017 Category: Consumer Health News Source Type: news
Why Big Pharma doesn't want a promising drug to reverse type 1 diabetes
Dr. Denise Faustman has been working for eight years on using a low-cost tuberculosis vaccine to permanently reverse type I diabetes. But pharmaceutical companies have no interest. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 15, 2017 Category: American Health Authors: Jessica Bartlett Source Type: news
Mass. General study finds potential mechanism for BCG vaccine reversal of type 1 diabetes
(Massachusetts General Hospital) Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Gu é rin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2017 Category: International Medicine & Public Health Source Type: news
